Table 3.
Multivariate Cox regression analysis for miR-223 as a prognostic marker for DFS and OS.
| DFS | OS | ||||||
|---|---|---|---|---|---|---|---|
| Variable | HR | 95% CI | P value | HR | 95% CI | P value | |
| Molecular subtype | |||||||
| Luminal A | 1.924 | 0.681–5.433 | 0.217 | 2.452 | 0.487–12.341 | 0.277 | |
| Luminal B | 2.681 | 0.756–9.512 | 0.127 | 0.597 | 0.120–2.960 | 0.528 | |
| HER2-enriched | 6.421 | 0.793–51.969 | 0.081 | 100402 | 0.000–6.4E+191 | 0.958 | |
| Triple-negative | 5.997 | 2.128–16.903 | 0.001 | 3.142 | 1.063–9.283 | 0.038 | |
CI, confidence interval; HR, hazard ratio; DFS, disease-free survival; OS, overall survival. The covariates in the Cox model included miR-223 and TNM stage. The adjusted p value and HR were derived from the Cox model; miR-223 = 1 was used as a reference.
The p value of multivariate cox regression analysis for miR-223 in TNBC subtype is marked bold.